LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell[1].
Molecular Weight:
431.92
Purity:
99.05
CAS Number:
[1801253-04-2]
Formula:
C24H22ClN5O
Target:
Kallikrein
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted